Evidence map›Paper›PMID 38124143›Full record

ArticleActa neuropathologica communications2023

Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation.

Hideki Hayashi, Rie Saito, Hidetomo Tanaka, Norikazu Hara, Shin Koide, Yosuke Yonemochi, Tetsuo Ozawa, Mariko Hokari, Yasuko Toyoshima, Akinori Miyashita and 5 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Hideki HayashiDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Rie SaitoDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan. riesaito@bri.niigata-u.ac.jp.ORCID 0000-0001-7294-5183
Hidetomo TanakaDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Norikazu HaraDepartment of Molecular Genetics, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Shin KoideDepartment of Neurology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Yosuke YonemochiDepartments of Neurology, National Hospital Organization Niigata National Hospital, 3-52 Akasakachou, Kashiwazaki, 945-8585, Japan.
Tetsuo OzawaDepartment of Internal Medicine, National Hospital Organization Niigata National Hospital, 3-52 Akasakachou, Kashiwazaki, 945-8585, Japan.
Mariko HokariDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Yasuko ToyoshimaDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Akinori MiyashitaDepartment of Molecular Genetics, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Kouichirou OkamotoDepartment of Translational Research, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Takeshi IkeuchiDepartment of Molecular Genetics, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Takashi NakajimaDepartments of Neurology, National Hospital Organization Niigata National Hospital, 3-52 Akasakachou, Kashiwazaki, 945-8585, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-Ku, Niigata, 951-8585, Japan.
Niigata University · JPNational Hospital Organization · JPNiigata City General Hospital · JPToranomon Hospital · JP

Funding

Japan Agency for Medical Research and Development 21445852Japan Agency for Medical Research and Development JP22dk0207060Japan Society for the Promotion of Science 20K16595Japan Society for the Promotion of Science 21383002Japan Society for the Promotion of Science 23H00434Ministry of Health, Labour and Welfare 23FC1008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Charcot-Marie-Tooth DiseaseGenotypeGTP PhosphohydrolasesHumansMitochondrial ProteinsMutationGTP PhosphohydrolasesMFN2 protein, humanMitochondrial Proteins

Identifiers

PMID38124143
PMCPMC10734194
OpenAlexW4389995792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.